AGT 2010 CALL FOR ABSTRACTS ABSTRACT DUE DATE: Friday, February 12th, 2010
The 35th Annual Meeting Program Committee invites all interested persons to submit abstracts for the Association of Genetic Technologists’ 35th Annual Meeting, June 3-5, 2010, in Phoenix, Arizona. Abstracts will be printed in the Final Program & Abstract Book and in the 2009 Third Quarter issue of the Journal of the Association of Genetic Technologists if they are presented at the meeting. All abstracts must contain:
-
a description of the experiment,
-
a statement of results (including data), and
-
an informative conclusion.
Abstracts will be assigned to platform or poster presentations by the Program Committee. The Committee will consider the author’s preference and the time constraints of the meeting.
Poster Presentations Poster set-up will take place on Thursday, June 3, 2010 from 1:00 p.m. – 5:00 p.m. Posters will be available for viewing beginning the evening of June 3 through 12:00 noon Saturday, June 5. Poster presentations are scheduled for Friday, June 4 and Saturday, June 5. Posters will be displayed on 4’ x 4’ poster boards. They are held in place with push pins. You must supply your own pins. Posters must be dismantled by 2:00 p.m. on Saturday, June 5, 2010.
Platform Presentations Platform presentations are limited to fifteen (15) minutes each: twelve minutes for the presentation and three minutes for questions/discussion. You must request any audiovisual equipment through the AGT Executive Office prior to the meeting. If AGT accepts your abstract for platform presentation, you will receive notification by March 26, 2010. Abstracts not accepted for platform presentation may be accepted for poster presentation.
Submission Requirements Abstracts must be submitted electronically. Microsoft Word documents (.doc) are preferred. However, formats compatible with Microsoft also will be accepted. If the AGT Executive Office is unable to open your document you will be asked to re-submit the document in a text format (.txt). Documents should be typed in Arial font, 12-point size. Submissions must be e-mailed as a file attachment to the AGT Executive Office at agt-info@goAMP.com. If you are submitting more than one abstract, you must submit each abstract in a separate e-mail. Facsimile and/or handwritten submissions will not be accepted. The lead author on the abstract must be an AGT member at the time of submission.
The entire abstract, including title, author(s) and text, must contain no more than 350 words. The title of the abstract should be typed in all capital letters. List all authors, underlining the author who is presenting. Skip one line, indent three spaces, and type the text of the abstract in one paragraph.
When you complete the abstract, skip five lines and type the following information:
- Presenting author’s name, mailing address, telephone, fax, and e-mail address
- Indicate your presentation preference, i.e. Poster only, Platform only, Either Poster or Platform.
- Indicate if your abstract submission is intended for the AGT-Student Research Award competition. If so, you must include the student award application packet. Please ensure that the student member is listed as the first author.
- Identify the category into which your abstract fits:
- Cancer, Clinical, Prenatal, Other
- List key words of paper (40 characters maximum).
It is important that you follow all instructions carefully. Abstracts submitted incorrectly will not be considered for presentation.
ABSTRACTS MUST BE RECEIVED BY FRIDAY, February 12, 2010. PLEASE SUBMIT BY E-MAIL TO agt-info@goAMP.com.
Platform Presentation Abstract Selection Criteria
|
Point Range |
Criteria |
|
0 - 10 |
1. Purpose: Should be clear and concise; scientific merit or contribution stated.
(Why am I doing this?)
|
|
0 - 15 |
2. Hypothesis: May be incorporated into purpose. Should be clearly stated and appropriate for the purpose.
(What do I think might be the results?)
|
|
0 - 15 |
3. Scientific Method: Should be appropriate to the investigation, well stated and well organized.
(How did I do this study?)
|
|
0 - 15 |
4. Data: Should be clear, concise, specific and well organized.
(Results)
|
|
0 - 15 |
5. Interpretation: Specific and consistent with the data.
(What do the results mean?)
|
|
0 - 15 |
6. Conclusions: Organized, clear and consistent with the
data and interpretation. Should include the need for further investigation or suggest how other variables may influence results or further elucidate the questions addressed.
(What does this mean to patients/science?)
|
|
0 - 15 |
7. Overall Presentation: Consider validity, contribution to the field, use of references when appropriate, new technique, education tool, benefits to ALL areas of genetics. |
|
|
|
|